5W0X image
Deposition Date 2017-06-01
Release Date 2018-01-17
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5W0X
Title:
Crystal structure of mouse TOR signaling pathway regulator-like (TIPRL) delta 94-103
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.72 Å
R-Value Free:
0.27
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 63
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:TIP41-like protein
Gene (Uniprot):Tiprl
Chain IDs:A
Chain Length:240
Number of Molecules:1
Biological Source:Mus musculus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET modified residue
Primary Citation
Methylation-regulated decommissioning of multimeric PP2A complexes.
Nat Commun 8 2272 2272 (2017)
PMID: 29273778 DOI: 10.1038/s41467-017-02405-3

Abstact

Dynamic assembly/disassembly of signaling complexes are crucial for cellular functions. Specialized latency and activation chaperones control the biogenesis of protein phosphatase 2A (PP2A) holoenzymes that contain a common scaffold and catalytic subunits and a variable regulatory subunit. Here we show that the butterfly-shaped TIPRL (TOR signaling pathway regulator) makes highly integrative multibranching contacts with the PP2A catalytic subunit, selective for the unmethylated tail and perturbing/inactivating the phosphatase active site. TIPRL also makes unusual wobble contacts with the scaffold subunit, allowing TIPRL, but not the overlapping regulatory subunits, to tolerate disease-associated PP2A mutations, resulting in reduced holoenzyme assembly and enhanced inactivation of mutant PP2A. Strikingly, TIPRL and the latency chaperone, α4, coordinate to disassemble active holoenzymes into latent PP2A, strictly controlled by methylation. Our study reveals a mechanism for methylation-responsive inactivation and holoenzyme disassembly, illustrating the complexity of regulation/signaling, dynamic complex disassembly, and disease mutations in cancer and intellectual disability.

Legend

Protein

Chemical

Disease

Primary Citation of related structures